Document is current
Any future updates will be listed below
-
Authors
Choi, Jee Eun
Yan, Qi
Wang, Jianmin
Salgia, Nicholas J.
Muhitch, Jason B.
MacDonald, Cameron R.
Roberts, Nathan T.
James, Caitlin M.
McCarthy, Philip L.
Mohammadpour, Hemn
Daneshmandi, Saeed
Repasky, Elizabeth A.
-
Funding
Funding for this research was provided by:
National Cancer Institute
National Heart, Lung, and Blood Institute
American Society of Hematology
- License Information
-
More Information
Article History
Received: 17 November 2025
Accepted: 1 June 2026
First Online: 20 June 2026
Competing interests
: P.L.M. has received honoraria from and participated in advisory boards from Bristol Myers Squibb, Bluebird, Celgene, Janssen, Juno, Karyopharm, Magenta Therapeutics, Oncopeptides and Takeda. The remaining authors declare no competing interests.
